var eventsData = [{"Ticker":"FFIV","EffectiveDate":"2017-01-25","Type":"EarningsBeatRevenueMiss","Title":"After market close, FFIV reports 2017 Q1's earning $1.98 per share and revenue $515.958MM. This beats analyst's estimated EPS $1.94, misses estimated revenue $517.97MM.","DailyReturn":"1.11%","FiveDayReturnAfter":"-7.27%","FiveDayReturnBefore":"1.76%"},{"Ticker":"FFIV","EffectiveDate":"2016-12-14","Type":"RatingUpgrade","Title":"Citigroup upgrades FFIV to Buy from Neutral.","DailyReturn":"1.2%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"1.05%"},{"Ticker":"FFIV","EffectiveDate":"2016-11-30","Type":"RatingNeutral","Title":"Bernstein downgrades FFIV to Market Perform from Outperform. Target Price is $140.","DailyReturn":"-1.44%","FiveDayReturnAfter":"-1.37%","FiveDayReturnBefore":"-0.67%"},{"Ticker":"FFIV","EffectiveDate":"2016-11-09","Type":"RatingUpgrade","Title":"Nomura upgrades FFIV to Neutral from Reduce. Target Price is $130; previously $115.","DailyReturn":"1.78%","FiveDayReturnAfter":"4.03%","FiveDayReturnBefore":"0.57%"},{"Ticker":"FFIV","EffectiveDate":"2016-10-27","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold.","DailyReturn":"9.57%","FiveDayReturnAfter":"12.39%","FiveDayReturnBefore":"0.66%"},{"Ticker":"FFIV","EffectiveDate":"2016-10-27","Type":"RatingUpgrade","Title":"PiperJaffray upgrades FFIV to Overweight from Neutral.","DailyReturn":"9.57%","FiveDayReturnAfter":"12.39%","FiveDayReturnBefore":"0.66%"},{"Ticker":"FFIV","EffectiveDate":"2016-10-27","Type":"RatingNeutral","Title":"Goldman Sachs maintains FFIV to Neutral.","DailyReturn":"9.57%","FiveDayReturnAfter":"12.39%","FiveDayReturnBefore":"0.66%"},{"Ticker":"FFIV","EffectiveDate":"2016-10-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.97%","FiveDayReturnAfter":"15.57%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"FFIV","EffectiveDate":"2016-10-26","Type":"EarningsRevenueBeat","Title":"After market close, FFIV reports 2016 Q4's earning $2.11 per share and revenue $525.349MM. This beats analyst's estimated EPS $1.94, beats estimated revenue $520.45MM.","DailyReturn":"1.97%","FiveDayReturnAfter":"15.57%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"FFIV","EffectiveDate":"2016-10-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.97%","FiveDayReturnAfter":"15.57%","FiveDayReturnBefore":"-0.28%"},{"Ticker":"FFIV","EffectiveDate":"2016-09-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.86%","FiveDayReturnAfter":"3.38%","FiveDayReturnBefore":"1.62%"},{"Ticker":"FFIV","EffectiveDate":"2016-09-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.86%","FiveDayReturnAfter":"3.38%","FiveDayReturnBefore":"1.62%"},{"Ticker":"FFIV","EffectiveDate":"2016-09-14","Type":"RatingUpgrade","Title":"Oppenheimer upgrades FFIV to Outperform from Perform.","DailyReturn":"0.94%","FiveDayReturnAfter":"1.36%","FiveDayReturnBefore":"-6.29%"},{"Ticker":"FFIV","EffectiveDate":"2016-08-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.36%","FiveDayReturnAfter":"-0.3%","FiveDayReturnBefore":"0.66%"},{"Ticker":"FFIV","EffectiveDate":"2016-08-12","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.18%","FiveDayReturnAfter":"-1.1%","FiveDayReturnBefore":"1.36%"},{"Ticker":"FFIV","EffectiveDate":"2016-08-12","Type":"RatingNeutral","Title":"DA Davidson maintains FFIV to Buy. Target Price is $145; previously $125.34.","DailyReturn":"-0.18%","FiveDayReturnAfter":"-1.1%","FiveDayReturnBefore":"1.36%"},{"Ticker":"FFIV","EffectiveDate":"2016-07-21","Type":"RatingNeutral","Title":"Credit Suisse downgrades FFIV to Neutral from Outperform. Target Price is $125.","DailyReturn":"0.32%","FiveDayReturnAfter":"1.32%","FiveDayReturnBefore":"4.29%"},{"Ticker":"FFIV","EffectiveDate":"2016-07-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.72%","FiveDayReturnAfter":"2.82%","FiveDayReturnBefore":"2.34%"},{"Ticker":"FFIV","EffectiveDate":"2016-07-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.72%","FiveDayReturnAfter":"2.82%","FiveDayReturnBefore":"2.34%"},{"Ticker":"FFIV","EffectiveDate":"2016-07-20","Type":"EarningsRevenueBeat","Title":"After market close, FFIV reports 2016 Q3's earning $1.81 per share and revenue $496.522MM. This beats analyst's estimated EPS $1.79, beats estimated revenue $495.29MM.","DailyReturn":"0.72%","FiveDayReturnAfter":"2.82%","FiveDayReturnBefore":"2.34%"},{"Ticker":"FFIV","EffectiveDate":"2016-05-17","Type":"RatingNeutral","Title":"Pacific Crest downgrades FFIV to Sector Weight from Overweight.","DailyReturn":"-3.26%","FiveDayReturnAfter":"-0.63%","FiveDayReturnBefore":"5.23%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Citigroup maintains FFIV to Neutral. Target Price is $110; previously $95.","DailyReturn":"5.53%","FiveDayReturnAfter":"9.55%","FiveDayReturnBefore":"0.01%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Baird maintains FFIV to Neutral. Target Price is $110; previously $105.","DailyReturn":"5.53%","FiveDayReturnAfter":"9.55%","FiveDayReturnBefore":"0.01%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Buckingham Research maintains FFIV to Neutral. Target Price is $107; previously $105.","DailyReturn":"5.53%","FiveDayReturnAfter":"9.55%","FiveDayReturnBefore":"0.01%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Hold. Target Price is $99; previously $95.","DailyReturn":"5.53%","FiveDayReturnAfter":"9.55%","FiveDayReturnBefore":"0.01%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-21","Type":"RatingNeutral","Title":"Goldman Sachs maintains FFIV to Neutral. Target Price is $119; previously $111.","DailyReturn":"5.53%","FiveDayReturnAfter":"9.55%","FiveDayReturnBefore":"0.01%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-20","Type":"EarningsBeatRevenueMiss","Title":"After market close, FFIV reports 2016 Q2's earning $1.68 per share and revenue $483.677MM. This beats analyst's estimated EPS $1.63, misses estimated revenue $485.93MM.","DailyReturn":"1.46%","FiveDayReturnAfter":"9.56%","FiveDayReturnBefore":"0.59%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.46%","FiveDayReturnAfter":"9.56%","FiveDayReturnBefore":"0.59%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.46%","FiveDayReturnAfter":"9.56%","FiveDayReturnBefore":"0.59%"},{"Ticker":"FFIV","EffectiveDate":"2016-04-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.46%","FiveDayReturnAfter":"9.56%","FiveDayReturnBefore":"0.59%"},{"Ticker":"FFIV","EffectiveDate":"2016-03-16","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.78%","FiveDayReturnAfter":"5.27%","FiveDayReturnBefore":"-0.77%"},{"Ticker":"FFIV","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Overweight. Target Price is $5; previously $11.","DailyReturn":"-0.06%","FiveDayReturnAfter":"4.36%","FiveDayReturnBefore":"-3.71%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Market Perform. Target Price is $93; previously $108.","DailyReturn":"-0.56%","FiveDayReturnAfter":"5.74%","FiveDayReturnBefore":"-2.83%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Buckingham Research maintains FFIV to Neutral. Target Price is $105; previously $110.","DailyReturn":"-0.56%","FiveDayReturnAfter":"5.74%","FiveDayReturnBefore":"-2.83%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Hold. Target Price is $95; previously $100.","DailyReturn":"-0.56%","FiveDayReturnAfter":"5.74%","FiveDayReturnBefore":"-2.83%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Underweight. Target Price is $96; previously $98.","DailyReturn":"-0.56%","FiveDayReturnAfter":"5.74%","FiveDayReturnBefore":"-2.83%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains FFIV to Neutral. Target Price is $110; previously $115.","DailyReturn":"-0.56%","FiveDayReturnAfter":"5.74%","FiveDayReturnBefore":"-2.83%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-21","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $100; previously $115.","DailyReturn":"-0.56%","FiveDayReturnAfter":"5.74%","FiveDayReturnBefore":"-2.83%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.72%","FiveDayReturnAfter":"3.06%","FiveDayReturnBefore":"-0.02%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-20","Type":"EarningsRevenueBeat","Title":"After market close, FFIV reports 2016 Q1's earning $1.73 per share and revenue $489.486MM. This beats analyst's estimated EPS $1.6, beats estimated revenue $485.62MM.","DailyReturn":"-3.72%","FiveDayReturnAfter":"3.06%","FiveDayReturnBefore":"-0.02%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-3.72%","FiveDayReturnAfter":"3.06%","FiveDayReturnBefore":"-0.02%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-15","Type":"RatingNeutral","Title":"Sterne Agee CRT downgrades FFIV to Neutral from Buy.","DailyReturn":"-0.67%","FiveDayReturnAfter":"-0.41%","FiveDayReturnBefore":"2.51%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-14","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Underweight from Equal-Weight. Target Price is $98; previously $123.","DailyReturn":"0.17%","FiveDayReturnAfter":"-4.89%","FiveDayReturnBefore":"-1.07%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-14","Type":"RatingNeutral","Title":"RBC Capital maintains FFIV to Sector Perform. Target Price is $112; previously $115.","DailyReturn":"0.17%","FiveDayReturnAfter":"-4.89%","FiveDayReturnBefore":"-1.07%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-13","Type":"RatingNeutral","Title":"Pacific Crest maintains FFIV to Overweight. Target Price is $109; previously $149.","DailyReturn":"1.5%","FiveDayReturnAfter":"-2.83%","FiveDayReturnBefore":"-4.13%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-12","Type":"RatingNeutral","Title":"Deutsche Bank downgrades FFIV to Hold from Buy.","DailyReturn":"-0.97%","FiveDayReturnAfter":"-0.02%","FiveDayReturnBefore":"-3.58%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.55%","FiveDayReturnAfter":"-4.13%","FiveDayReturnBefore":"-0.49%"},{"Ticker":"FFIV","EffectiveDate":"2016-01-06","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.55%","FiveDayReturnAfter":"-4.13%","FiveDayReturnBefore":"-0.49%"},{"Ticker":"FFIV","EffectiveDate":"2015-12-09","Type":"RatingNeutral","Title":"Nomura downgrades FFIV to Reduce from Neutral. Target Price is $90.","DailyReturn":"-3%","FiveDayReturnAfter":"-3.64%","FiveDayReturnBefore":"-0.52%"},{"Ticker":"FFIV","EffectiveDate":"2015-11-13","Type":"RatingNeutral","Title":"JMP Securities downgrades FFIV to Market Perform from Market Outperform.","DailyReturn":"-4.08%","FiveDayReturnAfter":"-2.7%","FiveDayReturnBefore":"-3.04%"},{"Ticker":"FFIV","EffectiveDate":"2015-11-13","Type":"RatingNeutral","Title":"William Blair downgrades FFIV to Market Perform from Outperform.","DailyReturn":"-4.08%","FiveDayReturnAfter":"-2.7%","FiveDayReturnBefore":"-3.04%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Equal-Weight. Target Price is $123; previously $131.","DailyReturn":"-9.27%","FiveDayReturnAfter":"-8.89%","FiveDayReturnBefore":"3.58%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"Needham downgrades FFIV to Hold from Buy.","DailyReturn":"-9.27%","FiveDayReturnAfter":"-8.89%","FiveDayReturnBefore":"3.58%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"BMO Capital downgrades FFIV to Market Perform from Outperform. Target Price is $108; previously $140.","DailyReturn":"-9.27%","FiveDayReturnAfter":"-8.89%","FiveDayReturnBefore":"3.58%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"RBC Capital downgrades FFIV to Sector Perform from Outperform.","DailyReturn":"-9.27%","FiveDayReturnAfter":"-8.89%","FiveDayReturnBefore":"3.58%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-29","Type":"RatingNeutral","Title":"JMP Securities maintains FFIV to Market Outperform. Target Price is $125; previously $135.","DailyReturn":"-9.27%","FiveDayReturnAfter":"-8.89%","FiveDayReturnBefore":"3.58%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.87%","FiveDayReturnAfter":"-6.44%","FiveDayReturnBefore":"0.25%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-28","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.87%","FiveDayReturnAfter":"-6.44%","FiveDayReturnBefore":"0.25%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.87%","FiveDayReturnAfter":"-6.44%","FiveDayReturnBefore":"0.25%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-14","Type":"RatingNeutral","Title":"Barclays initiates coverage on FFIV to Equal-Weight. Target Price is $131.","DailyReturn":"-2.61%","FiveDayReturnAfter":"-0.53%","FiveDayReturnBefore":"2.22%"},{"Ticker":"FFIV","EffectiveDate":"2015-10-06","Type":"RatingNeutral","Title":"Citigroup initiates coverage on FFIV to Sell. Target Price is $105.","DailyReturn":"-4.05%","FiveDayReturnAfter":"-2.92%","FiveDayReturnBefore":"7.47%"},{"Ticker":"FFIV","EffectiveDate":"2015-09-25","Type":"RatingNeutral","Title":"Raymond James downgrades FFIV to Market Perform.","DailyReturn":"-0.94%","FiveDayReturnAfter":"0.94%","FiveDayReturnBefore":"-2%"},{"Ticker":"FFIV","EffectiveDate":"2015-09-22","Type":"RatingNeutral","Title":"Guggenheim downgrades FFIV to Neutral.","DailyReturn":"-2.16%","FiveDayReturnAfter":"-1.5%","FiveDayReturnBefore":"-1.09%"},{"Ticker":"FFIV","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $145; previously $140.","DailyReturn":"-2.19%","FiveDayReturnAfter":"-2.85%","FiveDayReturnBefore":"5.08%"},{"Ticker":"FFIV","EffectiveDate":"2015-08-03","Type":"RatingNeutral","Title":"Buckingham Research downgrades FFIV to Neutral from Buy.","DailyReturn":"-2.19%","FiveDayReturnAfter":"-2.85%","FiveDayReturnBefore":"5.08%"},{"Ticker":"FFIV","EffectiveDate":"2015-07-23","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Outperform. Target Price is $140; previously $127.","DailyReturn":"7.74%","FiveDayReturnAfter":"11.15%","FiveDayReturnBefore":"0.55%"},{"Ticker":"FFIV","EffectiveDate":"2015-07-22","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.19%","FiveDayReturnAfter":"10.61%","FiveDayReturnBefore":"0.01%"},{"Ticker":"FFIV","EffectiveDate":"2015-07-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.19%","FiveDayReturnAfter":"10.61%","FiveDayReturnBefore":"0.01%"},{"Ticker":"FFIV","EffectiveDate":"2015-07-06","Type":"RatingNeutral","Title":"Oppenheimer maintains FFIV to Outperform. Target Price is $133; previously $145.","DailyReturn":"-2.39%","FiveDayReturnAfter":"-3.42%","FiveDayReturnBefore":"-4.94%"},{"Ticker":"FFIV","EffectiveDate":"2015-06-29","Type":"RatingNeutral","Title":"PiperJaffray downgrades FFIV to Neutral from Overweight. Target Price is $130.","DailyReturn":"-2.84%","FiveDayReturnAfter":"-4.99%","FiveDayReturnBefore":"-2.67%"},{"Ticker":"FFIV","EffectiveDate":"2015-06-03","Type":"RatingNeutral","Title":"Nomura initiates coverage on FFIV to Neutral. Target Price is $118.","DailyReturn":"0.79%","FiveDayReturnAfter":"-0.45%","FiveDayReturnBefore":"-0.65%"},{"Ticker":"FFIV","EffectiveDate":"2015-06-01","Type":"RatingNeutral","Title":"Citigroup downgrades FFIV to Neutral from Buy. Target Price is $132; previously $122.","DailyReturn":"-0.46%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"-0.95%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingUpgrade","Title":"Needham upgrades FFIV to Buy from Hold.","DailyReturn":"1.64%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"2.78%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"MKM Partners downgrades FFIV to Neutral from Buy.","DailyReturn":"1.64%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"2.78%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $140.","DailyReturn":"1.64%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"2.78%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"PiperJaffray maintains FFIV to Overweight. Target Price is $130; previously $128.","DailyReturn":"1.64%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"2.78%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-23","Type":"RatingNeutral","Title":"Pacific Crest maintains FFIV to Overweight. Target Price is $149; previously $141.","DailyReturn":"1.64%","FiveDayReturnAfter":"2.72%","FiveDayReturnBefore":"2.78%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.25%","FiveDayReturnAfter":"5.44%","FiveDayReturnBefore":"4.81%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"1.25%","FiveDayReturnAfter":"5.44%","FiveDayReturnBefore":"4.81%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.25%","FiveDayReturnAfter":"5.44%","FiveDayReturnBefore":"4.81%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.25%","FiveDayReturnAfter":"5.44%","FiveDayReturnBefore":"4.81%"},{"Ticker":"FFIV","EffectiveDate":"2015-04-22","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.25%","FiveDayReturnAfter":"5.44%","FiveDayReturnBefore":"4.81%"},{"Ticker":"FFIV","EffectiveDate":"2015-03-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.6%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"FFIV","EffectiveDate":"2015-03-17","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.6%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"FFIV","EffectiveDate":"2015-03-17","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.6%","FiveDayReturnAfter":"1.88%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"FFIV","EffectiveDate":"2015-03-09","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Underperform from Equal-Weight. Target Price is $114.","DailyReturn":"-2.65%","FiveDayReturnAfter":"-4.86%","FiveDayReturnBefore":"-0.13%"},{"Ticker":"FFIV","EffectiveDate":"2015-03-04","Type":"RatingNeutral","Title":"Wedbush initiates coverage on FFIV to Outperform. Target Price is $140.","DailyReturn":"0.19%","FiveDayReturnAfter":"-5.81%","FiveDayReturnBefore":"-0.49%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-23","Type":"RatingNeutral","Title":"Citigroup maintains FFIV to Buy. Target Price is $122; previously $135.","DailyReturn":"1.27%","FiveDayReturnAfter":"0.51%","FiveDayReturnBefore":"-10.21%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-22","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Equal-Weight. Target Price is $114; previously $136.","DailyReturn":"-9.96%","FiveDayReturnAfter":"-10.99%","FiveDayReturnBefore":"-2.13%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-22","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades FFIV to Hold from Buy.","DailyReturn":"-9.96%","FiveDayReturnAfter":"-10.99%","FiveDayReturnBefore":"-2.13%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-22","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $140; previously $150.","DailyReturn":"-9.96%","FiveDayReturnAfter":"-10.99%","FiveDayReturnBefore":"-2.13%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-22","Type":"RatingUpgrade","Title":"Buckingham Research upgrades FFIV to Buy from Neutral.","DailyReturn":"-9.96%","FiveDayReturnAfter":"-10.99%","FiveDayReturnBefore":"-2.13%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.23%","FiveDayReturnAfter":"-10.91%","FiveDayReturnBefore":"-1.31%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-21","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.23%","FiveDayReturnAfter":"-10.91%","FiveDayReturnBefore":"-1.31%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-21","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.23%","FiveDayReturnAfter":"-10.91%","FiveDayReturnBefore":"-1.31%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-14","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Equal-Weight from Overweight. Target Price is $136.","DailyReturn":"-2.38%","FiveDayReturnAfter":"-2.13%","FiveDayReturnBefore":"1.51%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-06","Type":"RatingNeutral","Title":"Needham downgrades FFIV to Hold from Buy.","DailyReturn":"-2.33%","FiveDayReturnAfter":"-1.42%","FiveDayReturnBefore":"-2.96%"},{"Ticker":"FFIV","EffectiveDate":"2015-01-05","Type":"RatingUpgrade","Title":"Oppenheimer upgrades FFIV to Outperform from Market Perform. Target Price is $160.","DailyReturn":"-0.43%","FiveDayReturnAfter":"-0.33%","FiveDayReturnBefore":"-3.6%"},{"Ticker":"FFIV","EffectiveDate":"2014-11-14","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $130; previously $115.","DailyReturn":"2.16%","FiveDayReturnAfter":"1.43%","FiveDayReturnBefore":"0.74%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-31","Type":"RatingNeutral","Title":"Citigroup maintains FFIV to Buy. Target Price is $135; previously $120.","DailyReturn":"0.98%","FiveDayReturnAfter":"2.77%","FiveDayReturnBefore":"6.1%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains FFIV to Buy. Target Price is $145; previously $134.","DailyReturn":"3.97%","FiveDayReturnAfter":"6.84%","FiveDayReturnBefore":"3.81%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $118; previously $113.","DailyReturn":"3.97%","FiveDayReturnAfter":"6.84%","FiveDayReturnBefore":"3.81%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $115; previously $108.5.","DailyReturn":"3.97%","FiveDayReturnAfter":"6.84%","FiveDayReturnBefore":"3.81%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Overweight. Target Price is $136; previously $126.","DailyReturn":"3.97%","FiveDayReturnAfter":"6.84%","FiveDayReturnBefore":"3.81%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.6%","FiveDayReturnAfter":"4.38%","FiveDayReturnBefore":"3.07%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.6%","FiveDayReturnAfter":"4.38%","FiveDayReturnBefore":"3.07%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-2.6%","FiveDayReturnAfter":"4.38%","FiveDayReturnBefore":"3.07%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.6%","FiveDayReturnAfter":"4.38%","FiveDayReturnBefore":"3.07%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-29","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-2.6%","FiveDayReturnAfter":"4.38%","FiveDayReturnBefore":"3.07%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-14","Type":"RatingNeutral","Title":"Morgan Stanley maintains FFIV to Equal-Weight. Target Price is $113.","DailyReturn":"0.65%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"-11.29%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-14","Type":"RatingNeutral","Title":"Credit Suisse initiates coverage on FFIV to Outperform. Target Price is $140.","DailyReturn":"0.65%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"-11.29%"},{"Ticker":"FFIV","EffectiveDate":"2014-10-07","Type":"RatingNeutral","Title":"Bank of America maintains FFIV to Neutral. Target Price is $138; previously $120.","DailyReturn":"-3.47%","FiveDayReturnAfter":"-11.29%","FiveDayReturnBefore":"2.48%"},{"Ticker":"FFIV","EffectiveDate":"2014-09-29","Type":"RatingNeutral","Title":"Baird downgrades FFIV to Neutral from Outperform. Target Price is $125.","DailyReturn":"-1.55%","FiveDayReturnAfter":"1.32%","FiveDayReturnBefore":"-3.09%"},{"Ticker":"FFIV","EffectiveDate":"2014-09-11","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $150; previously $135.","DailyReturn":"0.74%","FiveDayReturnAfter":"0.19%","FiveDayReturnBefore":"1.02%"},{"Ticker":"FFIV","EffectiveDate":"2014-08-19","Type":"RatingUpgrade","Title":"ISI Group upgrades FFIV to Strong Buy from Buy.","DailyReturn":"2.95%","FiveDayReturnAfter":"4.18%","FiveDayReturnBefore":"-0.16%"},{"Ticker":"FFIV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $108.5; previously $101.","DailyReturn":"2.18%","FiveDayReturnAfter":"4.29%","FiveDayReturnBefore":"1.01%"},{"Ticker":"FFIV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $112; previously $110.","DailyReturn":"2.18%","FiveDayReturnAfter":"4.29%","FiveDayReturnBefore":"1.01%"},{"Ticker":"FFIV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $114; previously $112.","DailyReturn":"2.18%","FiveDayReturnAfter":"4.29%","FiveDayReturnBefore":"1.01%"},{"Ticker":"FFIV","EffectiveDate":"2014-07-24","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Overweight. Target Price is $126; previously $123.","DailyReturn":"2.18%","FiveDayReturnAfter":"4.29%","FiveDayReturnBefore":"1.01%"},{"Ticker":"FFIV","EffectiveDate":"2014-07-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.16%","FiveDayReturnAfter":"1.91%","FiveDayReturnBefore":"1.25%"},{"Ticker":"FFIV","EffectiveDate":"2014-07-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.16%","FiveDayReturnAfter":"1.91%","FiveDayReturnBefore":"1.25%"},{"Ticker":"FFIV","EffectiveDate":"2014-07-09","Type":"RatingNeutral","Title":"D.A. Davidson initiates coverage on FFIV to Buy. Target Price is $145.","DailyReturn":"2.37%","FiveDayReturnAfter":"1.41%","FiveDayReturnBefore":"-2.06%"},{"Ticker":"FFIV","EffectiveDate":"2014-06-19","Type":"RatingNeutral","Title":"Buckingham Research initiates coverage on FFIV to Neutral. Target Price is $128.","DailyReturn":"-2.68%","FiveDayReturnAfter":"-3.29%","FiveDayReturnBefore":"0.15%"},{"Ticker":"FFIV","EffectiveDate":"2014-06-18","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on FFIV to Equal-weight.","DailyReturn":"-0.89%","FiveDayReturnAfter":"-3.67%","FiveDayReturnBefore":"0.85%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $113; previously $111.","DailyReturn":"-2.04%","FiveDayReturnAfter":"-2.83%","FiveDayReturnBefore":"0.42%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Overweight. Target Price is $123; previously $120.","DailyReturn":"-2.04%","FiveDayReturnAfter":"-2.83%","FiveDayReturnBefore":"0.42%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $130.","DailyReturn":"-2.04%","FiveDayReturnAfter":"-2.83%","FiveDayReturnBefore":"0.42%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $112; previously $105.","DailyReturn":"-2.04%","FiveDayReturnAfter":"-2.83%","FiveDayReturnBefore":"0.42%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Pacific Crest maintains FFIV to Outperform. Target Price is $133; previously $120.","DailyReturn":"-2.04%","FiveDayReturnAfter":"-2.83%","FiveDayReturnBefore":"0.42%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-24","Type":"RatingNeutral","Title":"Bank of America maintains FFIV to Neutral. Target Price is $120; previously $112.","DailyReturn":"-2.04%","FiveDayReturnAfter":"-2.83%","FiveDayReturnBefore":"0.42%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.94%","FiveDayReturnAfter":"-3.68%","FiveDayReturnBefore":"2%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.94%","FiveDayReturnAfter":"-3.68%","FiveDayReturnBefore":"2%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-14","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades FFIV to Buy from Hold. Target Price is $120.","DailyReturn":"3.92%","FiveDayReturnAfter":"5.44%","FiveDayReturnBefore":"-1.37%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.21%","FiveDayReturnAfter":"3.87%","FiveDayReturnBefore":"-2.54%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-11","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-1.21%","FiveDayReturnAfter":"3.87%","FiveDayReturnBefore":"-2.54%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-10","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey initiates coverage on FFIV to Neutral. Target Price is $116.","DailyReturn":"-4.98%","FiveDayReturnAfter":"-1.32%","FiveDayReturnBefore":"0.47%"},{"Ticker":"FFIV","EffectiveDate":"2014-04-04","Type":"RatingNeutral","Title":"Northland initiates coverage on FFIV to Market Perform. Target Price is $113.","DailyReturn":"-2.36%","FiveDayReturnAfter":"-2.54%","FiveDayReturnBefore":"0.61%"},{"Ticker":"FFIV","EffectiveDate":"2014-03-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-3.69%","FiveDayReturnAfter":"1.63%","FiveDayReturnBefore":"-2.68%"},{"Ticker":"FFIV","EffectiveDate":"2014-02-10","Type":"RatingNeutral","Title":"Dougherty initiates coverage on FFIV to Buy. Target Price is $125.","DailyReturn":"2.06%","FiveDayReturnAfter":"4.22%","FiveDayReturnBefore":"0.24%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-23","Type":"RatingNeutral","Title":"Nomura downgrades FFIV to Neutral from Buy. Target Price is $111; previously $100.","DailyReturn":"5.13%","FiveDayReturnAfter":"9.76%","FiveDayReturnBefore":"3.08%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-23","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $100; previously $90.","DailyReturn":"5.13%","FiveDayReturnAfter":"9.76%","FiveDayReturnBefore":"3.08%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-23","Type":"RatingNeutral","Title":"McAdams Wright Ragen downgrades FFIV to Hold from Buy.","DailyReturn":"5.13%","FiveDayReturnAfter":"9.76%","FiveDayReturnBefore":"3.08%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.73%","FiveDayReturnAfter":"11.11%","FiveDayReturnBefore":"6.51%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.73%","FiveDayReturnAfter":"11.11%","FiveDayReturnBefore":"6.51%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"RatingNeutral","Title":"Nomura downgrades FFIV to Neutral from Buy. Target Price is $111; previously $100.","DailyReturn":"-0.73%","FiveDayReturnAfter":"11.11%","FiveDayReturnBefore":"6.51%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.73%","FiveDayReturnAfter":"11.11%","FiveDayReturnBefore":"6.51%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-22","Type":"RatingUpgrade","Title":"Janney Capital upgrades FFIV to Buy from Neutral. Target Price is $122; previously $83.","DailyReturn":"-0.73%","FiveDayReturnAfter":"11.11%","FiveDayReturnBefore":"6.51%"},{"Ticker":"FFIV","EffectiveDate":"2014-01-13","Type":"RatingNeutral","Title":"William Blair downgrades FFIV to Outperform from Market Perform.","DailyReturn":"3.94%","FiveDayReturnAfter":"9.06%","FiveDayReturnBefore":"0.55%"},{"Ticker":"FFIV","EffectiveDate":"2013-12-11","Type":"RatingNeutral","Title":"Citigroup initiates coverage on FFIV to Buy. Target Price is $100.","DailyReturn":"-0.56%","FiveDayReturnAfter":"-0.55%","FiveDayReturnBefore":"3.16%"},{"Ticker":"FFIV","EffectiveDate":"2013-11-22","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.03%","FiveDayReturnAfter":"-0.78%","FiveDayReturnBefore":"-1.36%"},{"Ticker":"FFIV","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $90; previously $88.","DailyReturn":"-1.34%","FiveDayReturnAfter":"-3.32%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"FFIV","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Buy. Target Price is $100; previously $97.","DailyReturn":"-1.34%","FiveDayReturnAfter":"-3.32%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"FFIV","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Bank of America downgrades FFIV to Neutral from Buy.","DailyReturn":"-1.34%","FiveDayReturnAfter":"-3.32%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"FFIV","EffectiveDate":"2013-10-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $107; previously $100.","DailyReturn":"-1.34%","FiveDayReturnAfter":"-3.32%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"FFIV","EffectiveDate":"2013-10-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-4.78%","FiveDayReturnAfter":"-7.42%","FiveDayReturnBefore":"3.47%"},{"Ticker":"FFIV","EffectiveDate":"2013-10-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-4.78%","FiveDayReturnAfter":"-7.42%","FiveDayReturnBefore":"3.47%"},{"Ticker":"FFIV","EffectiveDate":"2013-10-22","Type":"RatingNeutral","Title":"Pacific Crest maintains FFIV to Outperform.","DailyReturn":"0.59%","FiveDayReturnAfter":"-6.68%","FiveDayReturnBefore":"-0.11%"},{"Ticker":"FFIV","EffectiveDate":"2013-09-24","Type":"RatingNeutral","Title":"Goldman Sachs downgrades FFIV to Neutral from Buy. Target Price is $93.","DailyReturn":"-2.35%","FiveDayReturnAfter":"-3.84%","FiveDayReturnBefore":"-1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-09-19","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on FFIV to Buy. Target Price is $110.","DailyReturn":"0.17%","FiveDayReturnAfter":"-5.47%","FiveDayReturnBefore":"0.99%"},{"Ticker":"FFIV","EffectiveDate":"2013-08-12","Type":"RatingUpgrade","Title":"Barclays upgrades FFIV to Overweight from Equal-Weight. Target Price is $107; previously $89.","DailyReturn":"3.13%","FiveDayReturnAfter":"-2.69%","FiveDayReturnBefore":"1.6%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Buy. Target Price is $97; previously $88.","DailyReturn":"7.2%","FiveDayReturnAfter":"7.54%","FiveDayReturnBefore":"0.64%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $88; previously $85.","DailyReturn":"7.2%","FiveDayReturnAfter":"7.54%","FiveDayReturnBefore":"0.64%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Equal-Weight. Target Price is $89; previously $81.","DailyReturn":"7.2%","FiveDayReturnAfter":"7.54%","FiveDayReturnBefore":"0.64%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-25","Type":"RatingNeutral","Title":null,"DailyReturn":"7.2%","FiveDayReturnAfter":"7.54%","FiveDayReturnBefore":"0.64%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.88%","FiveDayReturnAfter":"9.51%","FiveDayReturnBefore":"-0.64%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-24","Type":"EarningBeat","Title":"FFIV reports 2013 Q3's earning $1.12 per share and revenue $370.3MM. This beats analyst's estimated EPS $1.08.","DailyReturn":"1.88%","FiveDayReturnAfter":"9.51%","FiveDayReturnBefore":"-0.64%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.88%","FiveDayReturnAfter":"9.51%","FiveDayReturnBefore":"-0.64%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-12","Type":"RatingUpgrade","Title":"PiperJaffray upgrades FFIV to Overweight from Neutral.","DailyReturn":"4.86%","FiveDayReturnAfter":"7.16%","FiveDayReturnBefore":"9.31%"},{"Ticker":"FFIV","EffectiveDate":"2013-07-12","Type":"RatingUpgrade","Title":"PiperJaffray upgrades FFIV to Overweight from Neutral. Target Price is $88; previously $80.","DailyReturn":"4.86%","FiveDayReturnAfter":"7.16%","FiveDayReturnBefore":"9.31%"},{"Ticker":"FFIV","EffectiveDate":"2013-06-28","Type":"RatingUpgrade","Title":"Raymond James upgrades FFIV to Outperform from Market Perform.","DailyReturn":"-1.78%","FiveDayReturnAfter":"-1.23%","FiveDayReturnBefore":"-3.18%"},{"Ticker":"FFIV","EffectiveDate":"2013-06-03","Type":"RatingNeutral","Title":"Morgan Stanley downgrades FFIV to Equal-Weight from Overweight.","DailyReturn":"-4.86%","FiveDayReturnAfter":"-6.37%","FiveDayReturnBefore":"2.42%"},{"Ticker":"FFIV","EffectiveDate":"2013-05-07","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on FFIV to Outperform.","DailyReturn":"-0.72%","FiveDayReturnAfter":"1.05%","FiveDayReturnBefore":"2.03%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-26","Type":"RatingNeutral","Title":"FBR Capital downgrades FFIV to Market Perform from Outperform. Target Price is $75; previously $120.","DailyReturn":"-0.92%","FiveDayReturnAfter":"-0.52%","FiveDayReturnBefore":"3.18%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-25","Type":"RatingUpgrade","Title":"Nomura upgrades FFIV to Buy from Neutral. Target Price is $88; previously $85.","DailyReturn":"3.51%","FiveDayReturnAfter":"2.41%","FiveDayReturnBefore":"-1.56%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.02%","FiveDayReturnAfter":"5.51%","FiveDayReturnBefore":"-2.2%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.02%","FiveDayReturnAfter":"5.51%","FiveDayReturnBefore":"-2.2%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.02%","FiveDayReturnAfter":"5.51%","FiveDayReturnBefore":"-2.2%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-24","Type":"RevenueBeat","Title":"After market close, FFIV reports 2013 Q2's earning $1.07 per share and revenue $350.2MM. This meets analyst's estimated EPS $1.07, misses estimated revenue $351.78MM.","DailyReturn":"0.02%","FiveDayReturnAfter":"5.51%","FiveDayReturnBefore":"-2.2%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Outperform. Target Price is $80; previously $120.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Topeka downgrades FFIV to Hold from Buy. Target Price is $70; previously $118.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $82; previously $91.5.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Sterne Agee maintains FFIV to Buy. Target Price is $95; previously $118.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $85; previously $105.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Wedbush maintains FFIV to Outperform. Target Price is $90; previously $112.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"PiperJaffray downgrades FFIV to Neutral from Overweight. Target Price is $82; previously $107.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"ISI Group maintains FFIV to Buy. Target Price is $95; previously $125.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Citigroup downgrades FFIV to Neutral from Buy. Target Price is $80; previously $125.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Goldman Sachs maintains FFIV to Buy. Target Price is $98; previously $111.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-05","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $85; previously $104.","DailyReturn":"-19.03%","FiveDayReturnAfter":"-17.5%","FiveDayReturnBefore":"1.89%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.11%","FiveDayReturnAfter":"-20.96%","FiveDayReturnBefore":"3.31%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.11%","FiveDayReturnAfter":"-20.96%","FiveDayReturnBefore":"3.31%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-03","Type":"RatingNeutral","Title":"Craig-Hallum initiates coverage on FFIV to Buy. Target Price is $110.","DailyReturn":"0.76%","FiveDayReturnAfter":"-21.5%","FiveDayReturnBefore":"2.65%"},{"Ticker":"FFIV","EffectiveDate":"2013-04-02","Type":"RatingUpgrade","Title":"Baird upgrades FFIV to Outperform from Neutral. Target Price is $110.","DailyReturn":"2.18%","FiveDayReturnAfter":"-18.9%","FiveDayReturnBefore":"1.02%"},{"Ticker":"FFIV","EffectiveDate":"2013-03-27","Type":"RatingUpgrade","Title":"McAdams Wright Ragen upgrades FFIV to Buy from Hold. Target Price is $110.","DailyReturn":"1.31%","FiveDayReturnAfter":"3.31%","FiveDayReturnBefore":"-2.4%"},{"Ticker":"FFIV","EffectiveDate":"2013-03-22","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $90; previously $105.","DailyReturn":"-2.26%","FiveDayReturnAfter":"0.05%","FiveDayReturnBefore":"-2.52%"},{"Ticker":"FFIV","EffectiveDate":"2013-03-13","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-0.71%","FiveDayReturnAfter":"-4.1%","FiveDayReturnBefore":"0.03%"},{"Ticker":"FFIV","EffectiveDate":"2013-03-13","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.71%","FiveDayReturnAfter":"-4.1%","FiveDayReturnBefore":"0.03%"},{"Ticker":"FFIV","EffectiveDate":"2013-03-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.71%","FiveDayReturnAfter":"-4.1%","FiveDayReturnBefore":"0.03%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-25","Type":"RatingNeutral","Title":"FBN Securities maintains FFIV to Sector Perform. Target Price is $110; previously $100.","DailyReturn":"2.14%","FiveDayReturnAfter":"1.59%","FiveDayReturnBefore":"5.88%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $104; previously $100.","DailyReturn":"4.46%","FiveDayReturnAfter":"6.02%","FiveDayReturnBefore":"1.39%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"Wunderlich maintains FFIV to Hold. Target Price is $105; previously $100.","DailyReturn":"4.46%","FiveDayReturnAfter":"6.02%","FiveDayReturnBefore":"1.39%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"PiperJaffray maintains FFIV to Overweight. Target Price is $107; previously $106.","DailyReturn":"4.46%","FiveDayReturnAfter":"6.02%","FiveDayReturnBefore":"1.39%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $105; previously $90.","DailyReturn":"4.46%","FiveDayReturnAfter":"6.02%","FiveDayReturnBefore":"1.39%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Outperform. Target Price is $120; previously $115.","DailyReturn":"4.46%","FiveDayReturnAfter":"6.02%","FiveDayReturnBefore":"1.39%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-24","Type":"RatingNeutral","Title":"McAdams Wright Ragen maintains FFIV to Hold. Target Price is $110.","DailyReturn":"4.46%","FiveDayReturnAfter":"6.02%","FiveDayReturnBefore":"1.39%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.19%","FiveDayReturnAfter":"8.06%","FiveDayReturnBefore":"-0.51%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-23","Type":"EarningsRevenueMiss","Title":"After market close, FFIV reports 2013 Q1's earning $1.14 per share and revenue $365.5MM. This misses analyst's estimated EPS $1.15, misses estimated revenue $366.91MM.","DailyReturn":"2.19%","FiveDayReturnAfter":"8.06%","FiveDayReturnBefore":"-0.51%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.19%","FiveDayReturnAfter":"8.06%","FiveDayReturnBefore":"-0.51%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-22","Type":"RatingNeutral","Title":"Needham downgrades FFIV to Hold from Buy.","DailyReturn":"-0.2%","FiveDayReturnAfter":"8.66%","FiveDayReturnBefore":"-1.02%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-3.81%","FiveDayReturnAfter":"-5.54%","FiveDayReturnBefore":"4.98%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-03","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-3.81%","FiveDayReturnAfter":"-5.54%","FiveDayReturnBefore":"4.98%"},{"Ticker":"FFIV","EffectiveDate":"2013-01-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.81%","FiveDayReturnAfter":"-5.54%","FiveDayReturnBefore":"4.98%"},{"Ticker":"FFIV","EffectiveDate":"2012-12-21","Type":"RatingNeutral","Title":"FBR Capital initiates coverage on FFIV to Outperform. Target Price is $120.","DailyReturn":"0.13%","FiveDayReturnAfter":"-1.23%","FiveDayReturnBefore":"3.76%"},{"Ticker":"FFIV","EffectiveDate":"2012-12-20","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $95; previously $83.","DailyReturn":"0.92%","FiveDayReturnAfter":"0.71%","FiveDayReturnBefore":"2.35%"},{"Ticker":"FFIV","EffectiveDate":"2012-12-19","Type":"RatingNeutral","Title":"Wedbush maintains FFIV to Outperform. Target Price is $110; previously $95.","DailyReturn":"-0.87%","FiveDayReturnAfter":"0.06%","FiveDayReturnBefore":"2.46%"},{"Ticker":"FFIV","EffectiveDate":"2012-11-13","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades FFIV to Buy from Neutral. Target Price is $106; previously $104.","DailyReturn":"0.46%","FiveDayReturnAfter":"2.22%","FiveDayReturnBefore":"1.17%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.99%","FiveDayReturnAfter":"6.95%","FiveDayReturnBefore":"-15.86%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Nomura maintains FFIV to Neutral. Target Price is $100; previously $109.","DailyReturn":"-11.05%","FiveDayReturnAfter":"-12.21%","FiveDayReturnBefore":"-4.2%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Wunderlich downgrades FFIV to Hold from Buy. Target Price is $100; previously $115.","DailyReturn":"-11.05%","FiveDayReturnAfter":"-12.21%","FiveDayReturnBefore":"-4.2%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"BMO Capital maintains FFIV to Outperform. Target Price is $115; previously $125.","DailyReturn":"-11.05%","FiveDayReturnAfter":"-12.21%","FiveDayReturnBefore":"-4.2%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Oppenheimer downgrades FFIV to Perform from Outperform.","DailyReturn":"-11.05%","FiveDayReturnAfter":"-12.21%","FiveDayReturnBefore":"-4.2%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $90; previously $110.","DailyReturn":"-11.05%","FiveDayReturnAfter":"-12.21%","FiveDayReturnBefore":"-4.2%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Barclays maintains FFIV to Equal-Weight. Target Price is $90; previously $105.","DailyReturn":"-11.05%","FiveDayReturnAfter":"-12.21%","FiveDayReturnBefore":"-4.2%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"FBN Securities maintains FFIV to Sector Perform. Target Price is $100; previously $120.","DailyReturn":"-11.05%","FiveDayReturnAfter":"-12.21%","FiveDayReturnBefore":"-4.2%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-25","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $116; previously $136.","DailyReturn":"-11.05%","FiveDayReturnAfter":"-12.21%","FiveDayReturnBefore":"-4.2%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-24","Type":"EarningsRevenueMiss","Title":"After market close, FFIV reports 2012 Q4's earning $1.12 per share and revenue $362.6MM. This misses analyst's estimated EPS $1.18, misses estimated revenue $365.87MM.","DailyReturn":"-2.32%","FiveDayReturnAfter":"-10.4%","FiveDayReturnBefore":"-5.74%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.32%","FiveDayReturnAfter":"-10.4%","FiveDayReturnBefore":"-5.74%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.32%","FiveDayReturnAfter":"-10.4%","FiveDayReturnBefore":"-5.74%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-15","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.06%","FiveDayReturnAfter":"-1.48%","FiveDayReturnBefore":"-6.14%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-15","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.06%","FiveDayReturnAfter":"-1.48%","FiveDayReturnBefore":"-6.14%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.06%","FiveDayReturnAfter":"-1.48%","FiveDayReturnBefore":"-6.14%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-09","Type":"RatingNeutral","Title":"Buckingham Research initiates coverage on FFIV to Neutral.","DailyReturn":"-1.73%","FiveDayReturnAfter":"-5.51%","FiveDayReturnBefore":"-0.77%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-05","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Equal-Weight from Overweight. Target Price is $105; previously $115.","DailyReturn":"-3.72%","FiveDayReturnAfter":"-8.38%","FiveDayReturnBefore":"0.86%"},{"Ticker":"FFIV","EffectiveDate":"2012-10-05","Type":"RatingNeutral","Title":"Barclays downgrades FFIV to Equal-Weight from Overweight.","DailyReturn":"-3.72%","FiveDayReturnAfter":"-8.38%","FiveDayReturnBefore":"0.86%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $99; previously $101.","DailyReturn":"4.21%","FiveDayReturnAfter":"-6.93%","FiveDayReturnBefore":"6.41%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"Goldman Sachs maintains FFIV to Neutral. Target Price is $109; previously $123.","DailyReturn":"4.21%","FiveDayReturnAfter":"-6.93%","FiveDayReturnBefore":"6.41%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $136; previously $140.","DailyReturn":"4.21%","FiveDayReturnAfter":"-6.93%","FiveDayReturnBefore":"6.41%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"McAdams Wright Ragen maintains FFIV to Hold. Target Price is $120; previously $130.","DailyReturn":"4.21%","FiveDayReturnAfter":"-6.93%","FiveDayReturnBefore":"6.41%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"PiperJaffray maintains FFIV to Overweight. Target Price is $130; previously $150.","DailyReturn":"4.21%","FiveDayReturnAfter":"-6.93%","FiveDayReturnBefore":"6.41%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $110; previously $120.","DailyReturn":"4.21%","FiveDayReturnAfter":"-6.93%","FiveDayReturnBefore":"6.41%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"FBN Securities maintains FFIV to Sector Perform. Target Price is $120; previously $155.","DailyReturn":"4.21%","FiveDayReturnAfter":"-6.93%","FiveDayReturnBefore":"6.41%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"7.44%","FiveDayReturnAfter":"-2.56%","FiveDayReturnBefore":"0.43%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-18","Type":"RevenueBeat","Title":"After market close, FFIV reports 2012 Q3's earning $1.14 per share and revenue $352.6MM. This meets analyst's estimated EPS $1.14, misses estimated revenue $352.86MM.","DailyReturn":"7.44%","FiveDayReturnAfter":"-2.56%","FiveDayReturnBefore":"0.43%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"7.44%","FiveDayReturnAfter":"-2.56%","FiveDayReturnBefore":"0.43%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-16","Type":"RatingNeutral","Title":"Morgan Stanley maintains FFIV to Overweight. Target Price is $125; previously $155.","DailyReturn":"0.78%","FiveDayReturnAfter":"5.02%","FiveDayReturnBefore":"-3.33%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-13","Type":"RatingNeutral","Title":"Sterne Agee maintains FFIV to Buy. Target Price is $121; previously $141.","DailyReturn":"-2.22%","FiveDayReturnAfter":"9.46%","FiveDayReturnBefore":"-8.18%"},{"Ticker":"FFIV","EffectiveDate":"2012-07-13","Type":"RatingNeutral","Title":"Wedbush maintains FFIV to Outperform. Target Price is $117; previously $130.","DailyReturn":"-2.22%","FiveDayReturnAfter":"9.46%","FiveDayReturnBefore":"-8.18%"},{"Ticker":"FFIV","EffectiveDate":"2012-06-11","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains FFIV to Hold. Target Price is $110; previously $145.","DailyReturn":"-2.22%","FiveDayReturnAfter":"-0.23%","FiveDayReturnBefore":"5.09%"},{"Ticker":"FFIV","EffectiveDate":"2012-05-31","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $120; previously $140.","DailyReturn":"-3.77%","FiveDayReturnAfter":"-4.05%","FiveDayReturnBefore":"-8.03%"},{"Ticker":"FFIV","EffectiveDate":"2012-05-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.44%","FiveDayReturnAfter":"-10.94%","FiveDayReturnBefore":"-7.03%"},{"Ticker":"FFIV","EffectiveDate":"2012-05-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.44%","FiveDayReturnAfter":"-10.94%","FiveDayReturnBefore":"-7.03%"},{"Ticker":"FFIV","EffectiveDate":"2012-05-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $140; previously $150.","DailyReturn":"-7.87%","FiveDayReturnAfter":"-12.99%","FiveDayReturnBefore":"-0.35%"},{"Ticker":"FFIV","EffectiveDate":"2012-05-17","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.51%","FiveDayReturnAfter":"-0.35%","FiveDayReturnBefore":"-8.99%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-23","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on FFIV to Overweight. Target Price is $155.","DailyReturn":"-0.59%","FiveDayReturnAfter":"3.34%","FiveDayReturnBefore":"7.49%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $150; previously $135.","DailyReturn":"7.86%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.26%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $134; previously $122.","DailyReturn":"7.86%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.26%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"Miller Tabak maintains FFIV to Buy. Target Price is $165; previously $160.","DailyReturn":"7.86%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.26%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $140; previously $127.","DailyReturn":"7.86%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.26%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"Jefferies maintains FFIV to Hold. Target Price is $125; previously $112.5.","DailyReturn":"7.86%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.26%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingUpgrade","Title":"Wunderlich upgrades FFIV to Buy from Hold. Target Price is $145; previously $120.","DailyReturn":"7.86%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.26%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"FBN Securities maintains FFIV to Sector Perform. Target Price is $155; previously $135.","DailyReturn":"7.86%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.26%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-19","Type":"RatingNeutral","Title":"ISI Group maintains FFIV to Buy. Target Price is $150; previously $130.","DailyReturn":"7.86%","FiveDayReturnAfter":"5.1%","FiveDayReturnBefore":"1.26%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.37%","FiveDayReturnAfter":"4.37%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-18","Type":"EarningsRelease","Title":"After market close, FFIV reports 2012 Q2's earning $0.86 per share and revenue $339.622MM..","DailyReturn":"0.37%","FiveDayReturnAfter":"4.37%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.37%","FiveDayReturnAfter":"4.37%","FiveDayReturnBefore":"-3.61%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-16","Type":"RatingNeutral","Title":"JP Morgan maintains FFIV to Neutral. Target Price is $122; previously $120.","DailyReturn":"-0.06%","FiveDayReturnAfter":"7.49%","FiveDayReturnBefore":"-10.71%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-13","Type":"RatingNeutral","Title":"PiperJaffray maintains FFIV to Overweight. Target Price is $150; previously $125.","DailyReturn":"-1.63%","FiveDayReturnAfter":"7.62%","FiveDayReturnBefore":"-9.19%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-09","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades FFIV to Hold from Buy. Target Price is $140.","DailyReturn":"-2.24%","FiveDayReturnAfter":"-10.71%","FiveDayReturnBefore":"0.79%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-03","Type":"RatingNeutral","Title":"Oppenheimer maintains FFIV to Outperform. Target Price is $150; previously $130.","DailyReturn":"1.02%","FiveDayReturnAfter":"-6.31%","FiveDayReturnBefore":"1.37%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-03","Type":"RatingNeutral","Title":"Bank oferica maintains FFIV to Buy. Target Price is $145; previously $136.","DailyReturn":"1.02%","FiveDayReturnAfter":"-6.31%","FiveDayReturnBefore":"1.37%"},{"Ticker":"FFIV","EffectiveDate":"2012-04-02","Type":"RatingNeutral","Title":"Deutsche Bank maintains FFIV to Buy. Target Price is $135; previously $130.","DailyReturn":"1.25%","FiveDayReturnAfter":"-1.55%","FiveDayReturnBefore":"2.11%"},{"Ticker":"FFIV","EffectiveDate":"2012-03-28","Type":"RatingNeutral","Title":"Wedbush maintains FFIV to Outperform. Target Price is $147; previously $125.","DailyReturn":"-0.04%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"3.49%"},{"Ticker":"FFIV","EffectiveDate":"2012-03-28","Type":"RatingNeutral","Title":"FBN Securities downgrades FFIV to Sector Perform from Outperform. Target Price is $135; previously $125.","DailyReturn":"-0.04%","FiveDayReturnAfter":"2.9%","FiveDayReturnBefore":"3.49%"},{"Ticker":"FFIV","EffectiveDate":"2012-03-19","Type":"RatingNeutral","Title":"Sterne Agee maintains FFIV to Buy. Target Price is $141; previously $123.","DailyReturn":"0.62%","FiveDayReturnAfter":"0.16%","FiveDayReturnBefore":"4.89%"},{"Ticker":"FFIV","EffectiveDate":"2012-03-15","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.34%","FiveDayReturnAfter":"-0.37%","FiveDayReturnBefore":"5.54%"},{"Ticker":"FFIV","EffectiveDate":"2012-03-07","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on FFIV to Hold. Target Price is $145.","DailyReturn":"2.87%","FiveDayReturnAfter":"9.03%","FiveDayReturnBefore":"-4.64%"},{"Ticker":"FFIV","EffectiveDate":"2012-03-05","Type":"RatingNeutral","Title":"UBS maintains FFIV to Neutral. Target Price is $127; previously $110.","DailyReturn":"-1.98%","FiveDayReturnAfter":"-1.1%","FiveDayReturnBefore":"-0.36%"}];